Tolerance to Islet Allotransplants in Diabetes

Conditions: Diabetes Mellitus Type 2 - Insulin-Treated Interventions: Biological: ToleraCell-001; Biological: ToleraCell-002; Drug: DFI-105; Drug: Etanercept; Drug: Tocilizumab; Drug: Sirolimus Sponsors: Diabetes Free, Inc. Not yet recruiting

https://clinicaltrials.gov/study/NCT06160544

Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials